AbbVie Inc. (ABBV)
- Previous Close
169.54 - Open
168.59 - Bid 167.80 x 800
- Ask 167.92 x 800
- Day's Range
166.74 - 169.11 - 52 Week Range
130.96 - 182.89 - Volume
2,918,594 - Avg. Volume
5,623,520 - Market Cap (intraday)
297.115B - Beta (5Y Monthly) 0.56
- PE Ratio (TTM)
61.92 - EPS (TTM)
2.71 - Earnings Date Apr 26, 2024
- Forward Dividend & Yield 6.20 (3.66%)
- Ex-Dividend Date Apr 12, 2024
- 1y Target Est
184.70
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
www.abbvie.com50,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: ABBV
Performance Overview: ABBV
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ABBV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ABBV
Valuation Measures
Market Cap
300.20B
Enterprise Value
346.76B
Trailing P/E
62.33
Forward P/E
15.24
PEG Ratio (5yr expected)
0.47
Price/Sales (ttm)
5.53
Price/Book (mrq)
28.98
Enterprise Value/Revenue
6.38
Enterprise Value/EBITDA
20.19
Financial Highlights
Profitability and Income Statement
Profit Margin
8.95%
Return on Assets (ttm)
8.07%
Return on Equity (ttm)
35.20%
Revenue (ttm)
54.32B
Net Income Avi to Common (ttm)
4.82B
Diluted EPS (ttm)
2.71
Balance Sheet and Cash Flow
Total Cash (mrq)
12.82B
Total Debt/Equity (mrq)
582.66%
Levered Free Cash Flow (ttm)
22.63B
Research Analysis: ABBV
Company Insights: ABBV
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: ABBV
Analyst Report: AbbVie Inc
AbbVie, a research-based biopharmaceutical company, was spun off from Abbott Laboratories in January 2013. The company is based in suburban Chicago. The shares are a component of the S&P 500.
RatingPrice TargetMarket Digest: BK, ABBV
Strong First Quarter but Market Technicals send Red Flags
Daily – Vickers Top Buyers & Sellers for 03/21/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 03/04/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.